Research Articles | Page 2 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience Nov 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia Mar 2025 Blood Cancer Journal Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium Dec 2020 Cancer Medicine Myelodysplastic Syndromes (MDS)
Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis Apr 2019 Haemotologica Myelodysplastic Syndromes (MDS)
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice. Sep 2025 Blood Advances Aplastic Anemia
Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria Mar 2024 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Understanding infectious complications in patients with lower risk myelodysplastic syndromes: a step towards improving survival Jun 2025 Haematologica Myelodysplastic Syndromes (MDS)
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes. Jan 2019 Leuk Lymphoma. Myelodysplastic Syndromes (MDS)
Treatment options for lower-risk myelodysplastic syndromes. Where are we now? Jan 2021 Therapeutic Advances in Hematology Myelodysplastic Syndromes (MDS)
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations Aug 2024 Pediatric Blood Cancer Aplastic Anemia